# EMEND
> **NDA207865** · New Drug Application · Sponsor: MSD MERCK CO · Approved 2015-12-17
## Drug
- **FDA Application Number:** NDA207865
- **Application type:** New Drug Application
- **Brand name:** EMEND
- **Generic name:** APREPITANT
- **Active ingredients:** APREPITANT
- **Dosage form:** FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MSD MERCK CO
- **Manufacturer:** Merck Sharp & Dohme LLC
- **First approval:** 2015-12-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207865)
---
*AI Analytics · CC0 1.0*